About

Michael G. Neece at Morehead Planetarium Vault on 2018-11-02.
At the Morehead archives

Michael G. Neece lives in North Carolina, processing clinical trials data remotely for Gilead Sciences in California. In his free time, he presents star shows at Morehead Planetarium & Science Center under the same dome where astronauts once trained. And clearly, he writes. He is a firm believer in Rawls’ Veil of Ignorance as a conceptual framework for how to live.


More about the author

I first read Tunnel in the Sky by Robert Heinlein when I was ten. It infused me with wanderlust and the love of good stories. While pursuing careers in martial arts instruction, planetarium education, corporate technical training, high school teaching, and computer programming for the last 12 years, I have retained my love of good stories and storytellers.

When I remembered a dream and wrote it down in 2011, I didn’t expect it to become a book; however, I’m open enough to think “why not?” Thus was born Young Mister Tim: Past Imperfect.

When I was eager to find and read a book about the astronaut training at Morehead Planetarium & Science Center (it happened in the 60s and 70s), I found that there are no such books. I decided to research and write this history myself. Now, with the blessing of Morehead’s current director Todd Boyette, I am writing several books Morehead’s publishing wing intends to publish: personal stories of those who have worked at Morehead and children’s book adaptations of planetarium presentations.


Other Work?

I am lucky to work to improve patients’ lives by processing data used in clinical trials, trials that lead to medicines and therapies. Walking into a drug store, I see all kinds of drugs that benefit patients, some that I have been lucky enough to work on.

Being a clinical programmer places me several chain links in the clinical trial process away from any patient, but I know that some therapeutics I have worked on help HIV, liver disease, and transplant patients. I’ve even worked with a brilliant team on a potential treatment for Covid-19.